✦ LIBER ✦

A Randomized Phase II Study of Paclitaxel and Bevacizumab With and Without Gemcitabine as First-Line Treatment for Metastatic Breast Cancer

✍ Scribed by Adam Brufsky; Karen Hoelzer; Thaddeus Beck; Robert Whorf; Mark Keaton; Padma Nadella; Elisa Krill-Jackson; Joan Kroener; Edward Middleman; Michael Frontiera; Devchand Paul; Timothy Panella; Jane Bromund; Luping Zhao; Mauro Orlando; Fritz Tai; Martin D. Marciniak; Coleman Obasaju; John Hainsworth

Book ID: 113538921
Publisher: CIG Media Group, LP.
Year: 2011
Tongue: English
Weight: 441 KB
Volume: 11
Category: Article
ISSN: 1526-8209
DOI: 10.1016/j.clbc.2011.03.019

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Final results of a phase II study ofnab-

Final results of a phase II study ofnab-paclitaxel, bevacizumab, and gemcitabine as first-line therapy for patients with HER2-negative metastatic breast cancer

✍ Christopher Lobo; Gilberto Lopes; Odalys Baez; Aurelio Castrellon; Annapoorna Fe 📂 Article 📅 2010 🏛 Springer US 🌐 English ⚖ 268 KB

First-line therapy with gemcitabine and

First-line therapy with gemcitabine and paclitaxel in locally, recurrent or metastatic breast cancer: A phase II study

✍ Djelila Allouache; Sulochana R Gawande; Michele Tubiana-Hulin; Nicole Tubiana-Ma 📂 Article 📅 2005 🏛 BioMed Central 🌐 English ⚖ 275 KB

Biweekly gemcitabine–paclitaxel, gemcita

Biweekly gemcitabine–paclitaxel, gemcitabine–carboplatin, or gemcitabine–cisplatin as first-line treatment in metastatic breast cancer after anthracycline failure: a phase II randomized selection trial

✍ Binghe Xu; Zefei Jiang; Sung-Bae Kim; Shiying Yu; Jifeng Feng; Artur Malzyner; A 📂 Article 📅 2011 🏛 Springer Japan 🌐 English ⚖ 289 KB

Phase II study of gemcitabine, doxorubic

Phase II study of gemcitabine, doxorubicin and paclitaxel (GAT) as first-line chemotherapy for metastatic breast cancer: a translational research experience

✍ Alessandro Passardi; Ilaria Massa; Wainer Zoli; Lorenzo Gianni; Carlo Milandri; 📂 Article 📅 2006 🏛 BioMed Central 🌐 English ⚖ 267 KB

Phase II Study of Gemcitabine and Bevaci

Phase II Study of Gemcitabine and Bevacizumab As First-Line Treatment in Taxane-Pretreated, HER2-Negative, Locally Recurrent or Metastatic Breast Cancer

✍ Rachel Borson; Graydon Harker; James Reeves; Thaddeus Beck; Steven Hager; Willia 📂 Article 📅 2012 🏛 CIG Media Group, LP. 🌐 English ⚖ 387 KB

Gemcitabine and vinorelbine as second-li

Gemcitabine and vinorelbine as second-line treatment in patients with metastatic breast cancer: a phase II study

✍ Michela Donadio; Mara Ardine; Alfredo Berruti; Giuliana Ritorto; Elena Fea; Mari 📂 Article 📅 2003 🏛 Springer 🌐 English ⚖ 179 KB